Genomics Medicine Ireland announce 600 new jobs in Dublin
The jobs will be created over the next five years.
Irish life sciences company Genomics Medicine Ireland is to create 600 high-skilled jobs in Dublin over the next five years.
Ireland Strategic Investment Fund and leading global investors announced their backing of a significant expansion of Genomics Medicine Ireland (GMI), with an investment of up to €350 million.
The funding will allow GMI to undertake one of the largest genome sequencing programmes, with one in 10 people in Ireland taking part.
The aim of the programme is to further the search for better diagnostics and treatments for a range of illnesses which could benefit the healthcare of Irish patients.
Speaking on the announcement, Taoiseach Leo Varadkar said: "GMI is a real Irish life sciences success story. In just three years since their founding they have proven their capacity to deliver and to grow and, in partnership with the State’s Strategic Investment Fund, are now poised for a further exciting period of expansion.
"GMI’s success is a reflection on the wider success of Ireland as a location for the life sciences industry for more than 50 years. Twenty-four of the world’s largest pharma and biotech companies are located here, creating valuable employment and contributing to our economic success.
"As a country, we have continuously worked to attract and retain investment from the life sciences sector and we are now positioning for the next wave of knowledge-driven innovation being led by the genomics industry and the economic benefits that will bring.”